journal article·2015-12

Comparative study of serum protein binding to three different carbon-based nanomaterials

Maja Sopotnik, Adrijana Leonardi, Igor Križaj, Peter Dušak, Darko Makovec, Tina Mesarič, Nataša Poklar Ulrih, Ita Junkar, Kristina Sepčić, Damjana Drobne

Carbon· Volume 95
Publisher page

Abstract

Abstract Nanomaterials (NM) that enter a biological environment are immediately covered by a layer of proteins, which form a protein corona that governs further interactions of NM within the organism. In this study, we investigated the bovine serum albumin corona and the human serum protein corona, formed on three different carbon-based NM: carbon black, multi-walled carbon nanotubes, and graphene oxide. The serum protein corona of all three studied NM was found to be enriched with complement factors and apolipoproteins. In addition, by measuring the enzymatic activity of the serum butyrylcholinesterase, we have shown that also less abundant proteins could be included in and affected by the corona formation. The studied NM show NM-specific affinities towards albumin binding, both in the pure bovine serum albumin solution or in the human serum. Interestingly, graphene oxide has the lowest affinity towards albumin, but it shows the highest sorptive capacity for other serum proteins, including those present in small amounts.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (77)

Show source-provided references
1. Nanomedicine(s) under the microscope10.1021/mp200394t ↗
2. Designing the nanoparticle–biomolecule interface for “targeting and therapeutic delivery10.1016/j.jconrel.2012.04.009 ↗
3. Graphene and graphene oxide as new nanocarriers for drug delivery applications10.1016/j.actbio.2013.08.016 ↗
4. Graphene-based nanomaterials for drug delivery and tissue engineering10.1016/j.jconrel.2013.10.017 ↗
5. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles10.1073/pnas.0608582104 ↗
6. Biomolecular coronas provide the biological identity of nanosized materials10.1038/nnano.2012.207 ↗
7. The evolution of the protein corona around nanoparticles: a test study10.1021/nn202458g ↗
8. Effects of serum proteins on intracellular uptake and cytotoxicity of carbon nanoparticles10.1016/j.carbon.2009.01.026 ↗
9. Protein corona-mediated mitigation of cytotoxicity of graphene oxide10.1021/nn200021j ↗
10. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells10.1021/nn300223w ↗
11. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency10.1021/ja309812z ↗
12. Protein-nanoparticle interactions10.1016/S1748-0132(08)70014-8 ↗
13. Protein binding by functionalized multiwalled carbon nanotubes is governed by the surface chemistry of both parties and the nanotube diameter10.1021/jp710541j ↗
14. Modeling the time evolution of the nanoparticle-protein corona in a body fluid10.1371/journal.pone.0010949 ↗
15. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis10.1021/nn201950e ↗
16. Adsorption of villin headpiece onto graphene, carbon nanotube, and c60: effect of contacting surface curvatures on binding affinity10.1021/jp208967t ↗
17. Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance10.1021/nn400409h ↗
18. Comparison of nanotube–protein corona composition in cell culture media10.1002/smll.201202243 ↗
19. Differential plasma protein binding to metal oxide nanoparticles10.1088/0957-4484/20/45/455101 ↗
20. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles10.1016/j.nano.2008.08.001 ↗
21. Physical−chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles10.1021/ja107583h ↗
22. Protein- nanoparticle interactions: opportunities and challenges10.1021/cr100440g ↗
23. Identification of serum proteins bound to industrial nanomaterials10.1016/j.toxlet.2011.09.009 ↗
24. The protein corona of dendrimers: PAMAM binds and activates complement proteins in human plasma in a generation dependent manner10.1039/c2ra21866f ↗
25. Characterization of carbon nanotube protein corona by using quantitative proteomics10.1016/j.nano.2012.09.004 ↗
26. Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles10.1088/0957-4484/24/26/265103 ↗
27. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake10.1021/ja2084338 ↗
28. Time evolution of nanoparticle–protein corona in human plasma: relevance for targeted drug delivery10.1021/la401192x ↗
29. Surface coatings shape the protein corona of spions with relevance to their application in vivo10.1021/la302446h ↗
30. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake10.1021/nn300060u ↗
31. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy10.1016/j.addr.2009.03.009 ↗
32. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics10.1016/j.ijpharm.2007.04.036 ↗
33. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip® system10.1002/elps.200600694 ↗
34. Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain10.1016/j.jconrel.2006.12.012 ↗
35. Mapping the surface adsorption forces of nanomaterials in biological systems10.1021/nn203303c ↗
36. The adsorption–desorption process of bovine serum albumin on carbon nanotubes10.1016/j.jcis.2006.11.046 ↗
37. Binding of blood proteins to carbon nanotubes reduces cytotoxicity10.1073/pnas.1105270108 ↗
38. Complement activation and protein adsorption by carbon nanotubes10.1016/j.molimm.2005.02.006 ↗
39. Single-walled carbon nanotube surface control of complement recognition and activation10.1021/nn3055175 ↗
40. Quantification of uptake and localization of bovine serum albumin-stabilized single-wall carbon nanotubes in different human cell types10.1002/smll.201100437 ↗
41. Size-dependent cell uptake of protein-coated graphene oxide nanosheets10.1021/am300253c ↗
42. Regulation of enzyme activity through interactions with nanoparticles10.3390/ijms10104198 ↗
43. Structural changes of t4 lysozyme upon adsorption to silica nanoparticles measured by circular dichroism10.1006/jcis.1995.1431 ↗
44. Structure and function of enzymes adsorbed onto single-walled carbon nanotubes10.1021/la047994h ↗
45. Interaction of carbon nanoparticles to serum albumin: elucidation of the extent of perturbation of serum albumin conformations and thermodynamical parameters10.1016/j.jhazmat.2013.01.009 ↗
46. Impact of graphene oxide on the structure and function of important multiple blood components by a dose-dependent pattern: impact of GO on structure and function of multiple blood components
47. Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme10.1021/la0497200 ↗
48. Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability10.1021/la0484725 ↗
49. The structure and function of ribonuclease A upon interacting with carbon nanotubes10.1088/0957-4484/19/9/095102 ↗
50. Effect of curvature on the α-Helix breaking tendency of carbon based nanomaterials10.1021/jp110898r ↗
51. Evidence for charge-transfer-induced conformational changes in carbon nanostructure–protein corona10.1021/jp3085028 ↗
52. Tunable inhibition and denaturation of α-chymotrypsin with amino acid-functionalized gold nanoparticles10.1021/ja0512881 ↗
53. Interaction of nano-TiO2 with lysozyme: insights into the enzyme toxicity of nanosized particles10.1007/s11356-009-0153-1 ↗
54. Adsorption and inhibition of butyrylcholinesterase by different engineered nanoparticles10.1016/j.chemosphere.2009.12.051 ↗
55. Adsorption and inhibition of acetylcholinesterase by different nanoparticles10.1016/j.chemosphere.2009.05.015 ↗
56. Effects of surface curvature and surface characteristics of carbon-based nanomaterials on the adsorption and activity of acetylcholinesterase10.1016/j.carbon.2013.05.060 ↗
57. Cholinesterases, a target of pharmacology and toxicology10.5507/bp.2011.036 ↗
58. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans10.1038/bjp.2008.185 ↗
59. Evolution of cholinesterases in the animal kingdom10.1016/j.cbi.2010.03.043 ↗
60. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse10.1046/j.1471-4159.2000.751320.x ↗
61. Estimation of globular protein secondary structure from circular dichroism10.1021/bi00504a006 ↗
62. Conus consors Snail venom proteomics proposes functions, pathways, and novel families involved in its venomic system10.1021/pr3006155 ↗
63. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma10.1016/j.bcp.2005.09.002 ↗
64. Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins10.1021/pr049921p ↗
65. Proteomic characterization of engineered nanomaterial–protein interactions in relation to surface reactivity10.1021/nn101492k ↗
66. Hard corona composition and cellular toxicities of the graphene sheets10.1016/j.colsurfb.2013.03.049 ↗
67. Surface curvature relation to protein adsorption for carbon-based nanomaterials10.1038/srep10886 ↗
68. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles10.1016/j.ijpharm.2005.10.010 ↗
69. Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles10.1016/j.jconrel.2004.07.028 ↗
70. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system10.1016/j.biomaterials.2013.07.102 ↗
71. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles10.1021/nn406018q ↗
72. Rahman · 2013 · 15 · 21
73. Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity10.1021/nl062743+ ↗
74. Material properties in complement activation10.1016/j.addr.2011.06.002 ↗
75. Functional groups on polystyrene model nanoparticles: influence on protein adsorption10.1002/jbm.a.10371 ↗
76. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway10.1124/pr.54.4.561 ↗
77. Instantaneous physico-chemical analysis of suspension-based nanomaterials10.1038/srep09896 ↗